Not listed ALLOPLEX: A MULTIFUNCTIONAL, BIOACTIVE DRESSING FOR BURN WOUND CARE IN THE PREHOSPITAL ENVIRONMENT DE-OBLIGATE FUNDS TO CLOSE AWARD PER SECTION 711 OF THE NATIONAL DEFENSE AUTHORIZATION ACT (NDAA) 2019, THE US ARMY MEDICAL RESEARCH ACQUISITION ACTIVITY (USAMRAA), US ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND (USAMRDC) TRANSFERRED TO THE DEFENSE HEALTH AGENCY (DHA) FROM THE U.S. ARMY EFFECTIVE 01 OCTOBER 2022; AND (3) THIS MODIFICATION REFLECTS CHANGES CONSISTENT WITH THE TRANSFER TO DHA; AND DIVISION II HAS BEEN UPDATED TO SUPERSEDE DIVISION III, PART 2, SECTION C, 2.B. ELECTRONIC PAYMENT INSTRUCTIONS. ($87k) 9/18/25 Not listed THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE BY 12 MONTHS, AT NO ADDITIONAL COST TO THE GOVERNMENT, UNTIL 04/30/2023 $0 6/17/22 Not listed THE PURPOSE OF THIS MODIFICATION IS TO EXTEND THE PERIOD OF PERFORMANCE BY 12 MONTHS, AT NO ADDITIONAL COST TO THE GOVERNMENT, UNTIL 04/30/2022 PER THE RECIPIENT'S REQUEST DATED 03/12/2021. AN ANNUAL TECHNICAL PROGRESS REPORT WILL BE DUE 05/31/2021. A FINAL TECHNICAL REPORT WILL BE DUE NO LATER THAN 08/29/2022. SUBMISSIONS OF SF-425 FEDERAL FINANCIAL REPORTS AND QUARTERLY TECHNICAL PROGRESS REPORTS SHALL CONTINUE DURING THE EXTENSION PERIOD. SEE THE SUMMARY OF CHANGES ON THE FOLLOWING PAGES. $0 4/5/21 Not listed ALLOPLEX: A MULTIFUNCTIONAL, BIOACTIVE DRESSING FOR BURN WOUND CARE IN THE PREHOSPITAL ENVIRONMENT. THE PURPOSE OF THIS MODIFICATION IS TO REFLECT A CHANGE IN PI F ROM MEGHAN SAMBERG TO STEPHEN E. FISCHER PER THE RECIPIENT'S REQUEST DATED 10/22/2020. $0 10/28/20 Not listed P00001 - OBLIGATED AMOUNT $253,233 THE PURPOSE OF THIS MODIFICATION IS TO CORRECT THE CLIN INFORMATION FOR THE SPONSORING AGENCY TO READ THE U.S. ARMY MEDICAL RESEARCH AND DEVELOPMENT COMMAND ENDORSED BY THE U.S. ARMY. ALL OTHER TERMS AND CONDITIONS REMAIN UNCHANGED.,,EFFECTIVE DATE 19-MAY-2020, DATE SIGNED 20-MAY-2020, DATE DISTRIBUTED 5/21/2020, FAADC ENTERED 5/21/2020 $0 5/20/20